Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with OutcomeYves Allory, Francisco X. Real, Irene Lurkin et al.|European Urology|2013Cited by 289
A 3-Plex Methylation Assay Combined with the <i>FGFR3</i> Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided UrineRaju Kandimalla, Ellen C. Zwarthoff, Roy Masius et al.|Clinical Cancer Research|2013Cited by 59
Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancerWillemien Beukers, Ellen C. Zwarthoff, Raju Kandimalla et al.|Modern Pathology|2014Cited by 56
Abstract 4023: Genome-wide analysis of CpG island methylation identified OTX1, OSR1 and ONECUT2 as biomarkers for recurrent bladder cancer detection in voided urineRaju Kandimalla, Ellen C. Zwarthoff, Angela A.G. van Tilborg et al.|Cancer Research|2012Cited by 3